Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Pharmacists

Each week we present you with a featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates in the fields of medicine and healthcare.
The common gastric reflux drugs classified as proton pump inhibitors (P.P.I.’s) have been found to increase one’s risk for a heart attack in a study of nearly three million individuals, according to The New York Times. Previous studies found that...
According to Reuters, Ibrance, a breast cancer drug from Pfizer is currently in Phase III clinical trials of a new drug. The drug is designed to treat the most common type of breast cancer, estrogen-receptor positive, human epidermal growth factor...